Cancer Detection and Diagnosis Research in Pennsylvania
Cancer Detection and Diagnosis Research (93.394) awarded $213 million to recipients in Pennsylvania in 125 grants from fiscal 2021 to 2025, 7.9% of the program's national total. The Trustees of the University of Pennsylvania received the most, $63.6 million.
- Awarded in Pennsylvania$213 million
- Awards125
- Share of the program7.9%
- Rank among states4th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 61 | $35.9 million |
| FY 2022 | 71 | $42.7 million |
| FY 2023 | 74 | $48.3 million |
| FY 2024 | 66 | $44.0 million |
| FY 2025 | 55 | $42.0 million |
Recipients in Pennsylvania
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Trustees of the University of Pennsylvania | Colleges and universities | 47 | $63.6 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Other | 27 | $48.7 million |
| NRG Oncology Foundation Inc | Nonprofits | 1 | $22.3 million |
| Ecog-Acrin Medical Research Foundation, Inc. | Nonprofits | 1 | $20.5 million |
| Thomas Jefferson University | Colleges and universities | 16 | $20.0 million |
| The Children's Hospital of Philadelphia | Nonprofits | 8 | $16.2 million |
| Imcare Biotech, Inc. | Small businesses | 3 | $4.5 million |
| The Pennsylvania State University | Other | 3 | $3.1 million |
| Carnegie-Mellon University | Colleges and universities | 2 | $2.2 million |
| Trevarx Biomedical, Inc | Small businesses | 1 | $2.0 million |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Pennsylvania?
$213 million from fiscal 2021 to 2025, across 125 awards. Pennsylvania ranks 4th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Pennsylvania?
The largest recipient is The Trustees of the University of Pennsylvania, with $63.6 million in 47 awards. Next are University of Pittsburgh - of the Commonwealth System of Higher Education and NRG Oncology Foundation Inc.
Can organizations in Pennsylvania apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Pennsylvania
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Federal Transit Formula Grants
- Special Education Grants to States
- Child Care and Development Block Grant